SIGA Technologies Inc. logo

SIGA

NASDAQ

SIGA Technologies Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
$4.57+0.05 (+1.11%)
Website
News25/Ratings0

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was founded in 1995 and is headquartered in New York, New York.

Price$4.57+0.05 (+1.11%)
01:30 PM07:45 PM
News · 26 weeks16-100%
2025-10-26: 12025-11-02: 32025-11-09: 02025-11-16: 02025-11-23: 02025-11-30: 02025-12-07: 02025-12-14: 02025-12-21: 02025-12-28: 02026-01-04: 02026-01-11: 02026-01-18: 02026-01-25: 12026-02-01: 02026-02-08: 02026-02-15: 02026-02-22: 02026-03-01: 12026-03-08: 32026-03-15: 42026-03-22: 32026-03-29: 02026-04-05: 02026-04-12: 02026-04-19: 0
2025-10-262026-04-19
Mix1290d
  • Insider6(50%)
  • SEC Filings3(25%)
  • Earnings2(17%)
  • Dividends1(8%)

Latest news

25 items